Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.48 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.47 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.47 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.41 |
| ▸ | BID | P55957 | 3/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.41 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.41 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 1/20 | 0.41 |
| ▸ | PPARA | Q07869 | 1/20 | 0.41 |
| ▸ | EP300 | Q09472 | 1/20 | 0.41 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.41 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.41 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.41 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.41 |
| ▸ | THRA | P10827 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9026453 | 0.98 | CYP4F2 (0.49) | LIPGCYP4F2CYP4A11GABRA1GABRB2 | |
| SCHEMBL1150835 | 0.91 | CYP4A11 (0.46) | LIPGCYP4F2CYP4A11GABRA1GABRB2 | |
| SCHEMBL2178352 | 0.89 | LIPG (0.47) | LIPGCYP4F2CYP4A11BIDMCL1 | |
| SCHEMBL9672220 | 0.87 | LIPG (0.43) | LIPGCYP4F2CYP4A11BIDMCL1 | |
| SCHEMBL30750761 | 0.87 | LIPG (0.43) | LIPGCYP4F2CYP4A11BIDMCL1 | |
| SCHEMBL3026750 | 0.85 | LIPG (0.60) | LIPGCYP4F2CYP4A11BIDMCL1 | |
| SCHEMBL13552187 | 0.85 | LIPG (0.50) | LIPGCYP4F2CYP4A11BIDMCL1 | |
| SCHEMBL6686137 | 0.83 | LIPG (0.62) | LIPGBIDMCL1BCL2L1BAK1 | |
| SCHEMBL10698277 | 0.83 | LIPG (0.42) | LIPGCYP4F2CYP4A11BIDMCL1 | |
| SCHEMBL6065358 | 0.83 | LIPG (0.62) | LIPGBIDMCL1BCL2L1BAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090286944-A1 | SELECT PHENOL-HETEROCYCLE LIGANDS, METAL COMPLEXES FORMED THEREFROM, AND THEIR USES AS CATALYSTS | SYMYX TECHNOLOGIES, INC. (US) | 2009-11-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090286944-A1 | SELECT PHENOL-HETEROCYCLE LIGANDS, METAL COMPLEXES FORMED THEREFROM, AND THEIR USES AS CATALYSTS | WASF2, WEE1, CD40LG | LIPG 3947/4885CYP4F2 79/4885CYP4A11 633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.